NICE's 2019/2020 methods review: challenges and opportunities Clinical study 08 February 2020 Pages: 2 - 2
Abuse-deterrent formulation of morphine saves healthcare costs Clinical study 08 February 2020 Pages: 3 - 3
Assessing the optimal imaging approach for suspected appendicits Clinical study 08 February 2020 Pages: 5 - 5
CT optimal surveillance strategy in high-risk soft tissue sarcoma Clinical study 08 February 2020 Pages: 9 - 9
Dabigatran cost effective for stroke prevention in AF in China Clinical study 08 February 2020 Pages: 11 - 11
Dipeptidyl peptidase 4 inhibitors reduce costs in T2DM management Clinical study 08 February 2020 Pages: 12 - 12
Financial incentives may not reduce smoking in low-income adults Clinical study 08 February 2020 Pages: 13 - 13
Industry funding of patient groups common and lacks transparency Clinical study 08 February 2020 Pages: 16 - 16
Maternal and neonatal tetanus elimination requires financial investment Clinical study 08 February 2020 Pages: 17 - 17
Novel device for preventing contrast-induced kidney injury cost saving Clinical study 08 February 2020 Pages: 19 - 19
Potential cost impact of single-payer healthcare system in USA Clinical study 08 February 2020 Pages: 21 - 21
Pre-implantation genetic testing for aneuploidy in IVF incurs high cost Clinical study 08 February 2020 Pages: 22 - 22
PrEP more cost effective in patients at high risk of HIV infection Clinical study 08 February 2020 Pages: 23 - 23
Rifampicin reduces severe hepatotoxicity and costs versus isoniazid Clinical study 08 February 2020 Pages: 25 - 25
Thrombectomy saves costs after stroke with large vessel occlusion Clinical study 08 February 2020 Pages: 26 - 26
Tissue-engineered heart valves predicted to be cost effective Clinical study 08 February 2020 Pages: 27 - 27
Topical 5-fluorouracil first choice for treatment of actinic keratosis Clinical study 08 February 2020 Pages: 28 - 28
Transitional care services cost effective after hospitalisation for HF Clinical study 08 February 2020 Pages: 29 - 29
US spend on MS therapies still escalating despite generics on the market Non-clinical study 08 February 2020 Pages: 30 - 30
Vortioxetine in major depression: high success rates, acceptable cost Clinical study 08 February 2020 Pages: 31 - 31